Latest Articles

26. 02. 2021

List of reimbursed medicinal products valid as of 1.3.2021

Acting in compliance with Section 39n(1) of Act No. 48/1997 Coll., on Public Health Insurance, as amended (“Act”), the State Institute for Drug Control publishes the List...

 

29. 01. 2021

List of reimbursed medicinal products valid as of 1.2.2021

Acting in compliance with Section 39n(1) of Act No. 48/1997 Coll., on Public Health Insurance, as amended (“Act”), the State Institute for Drug Control publishes the List...

 

25. 01. 2021

Data Mailbox Set-up for Foreign Entities

The Ministry of Interior sets up data mailboxes upon request also for natural persons-entrepreneurs and legal entities-businesses incorporated in a foreign country.

 

13. 01. 2021

Requirements for Electronic Signature of Clinical Trial Applications Submitted In Fully Electronic Format

The electronic signature must meet the requirements of Regulation No 910/2014 on electronic identification and trust services for electronic transactions in the internal...

 

31. 12. 2020

List of reimbursed medicinal products valid as of 1.1.2021

Acting in compliance with Section 39n(1) of Act No. 48/1997 Coll., on Public Health Insurance, as amended (“Act”), the State Institute for Drug Control publishes the List...

 

30. 11. 2020

List of reimbursed medicinal products valid as of 1.12.2020

Acting in compliance with Section 39n(1) of Act No. 48/1997 Coll., on Public Health Insurance, as amended (“Act”), the State Institute for Drug Control publishes the List...

 

13. 11. 2020

IMP with GMO for the treatment of COVID in CT 12.11.2020

Information on documentation to be submitted for clinical trials on medicinal products for the treatment of COVID-19, 7.11.2020, updated 12.11.2020